use of cetirizine in infants 3-6 months
Phase 1
- Conditions
- Cetirizine.
- Registration Number
- IRCT20110531006660N8
- Lead Sponsor
- Mazandaran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
infants with 3-6 months age;urticaria;eczema
Exclusion Criteria
sleep apnea in infant or another siblings
sensitivity to cetirizine
use of other antihistamines
QT interval more than 45 ms
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical resolution of urticaria and eczema. Timepoint: Before and after 10 days treatment. Method of measurement: Visit and ECG.
- Secondary Outcome Measures
Name Time Method Side effects of drug. Timepoint: 10 days. Method of measurement: Visit and ECG.